期刊文献+

儿童原发性限制型心肌病三例的临床特征及遗传分析 被引量:6

Clinical characteristics and genetic analysis of three pediatric patients with idiopathic restrictive cardiomyopathy
原文传递
导出
摘要 目的研究3例儿童原发性限制型心肌病( restrictive cardiomyopathy, RCM)的临床特征及心肌病理改变,并进行心肌肌节蛋白基因突变分析,以期发现遗传致病基础。方法采集和分析3例RCM患儿及其父母的临床资料。同时选择100名健康儿童作为正常对照。病例1和病例2接受心肌活检,标本行常规组织学和电镜检查。聚合酶链式反应(PCR)扩增RCM患儿肌钙蛋白I、肌钙蛋白T、β肌球蛋白重链、肌动蛋白基因编码外显子及附近上下游序列,直接双向测序并进行分析。如发现突变,则进一步检测该突变在患儿父母及正常对照儿童中的分布情况。结果3例患儿病情呈进行性加重。病例1合并小型膜周部室间隔缺损,病例2合并室间隔中下段轻度肥厚。组织学检查提示病例1存在广泛的心肌细胞排列紊乱和轻度纤维化,电镜显示肌节数量减少,线粒体显著增大变形;病例2心肌细胞轻度肥厚和间质纤维化,电镜检查显示z线排列紊乱,间距不规则。遗传分析分别在病例1和病例3中发现了肌钙蛋白I基因R204H、R192H杂合突变,在病例2中发现了肌钙蛋白T基因100—101delNE杂合突变,所有突变所在蛋白序列均高度保守。所有突变只出现在患儿,而父母及100名正常对照儿童中均未检测到相同突变。结论3例RCM患儿确诊后病情均进展迅速。3例患儿进行遗传分析均发现了致病突变,其中2个为肌钙蛋白I基因突变,1个为肌钙蛋白T基因突变。研究结果有助于加深对儿童原发性RCM发病机制的认识。 Objective Restrictive cardiomyopathy (RCM) is rare in children, and little is known about the molecular basis of RCM. The aim of this study was to investigate the clinical and myopathological characteristics and to detect mutations on cardiac sarcomere protein genes in three idiopathic pediatric RCMs. Methods Detailed clinical characteristies and familiar history were obtained in three idiopathic pediatric RCMs. One hundred healthy pediatric individuals were recruited as controls. Histological evaluation was performed with heart tissue retrieved at catheterization in case-1 and case-2. The entire coding sequences of four cardiac sarcomere protein genes, including cardiac troponin T (TNNT2), cardiac troponin I( TNNI3 ), 13-myosin heavy chain( MYH7 ), and α-actin (ACTC) were screened for mutations. Sequence variants were then tested in the family as well as in 100 healthy control DNAs. Results All three index cases were diagnosed as primary RCMs without family history, and their clinical conditions deteriorated rapidly. Case-1 was in combination with ventricular septal defect. Case-2 was in combination with mid- and inferoseptal hypertrophy. In case-l, myocardial biopsies displayed extensive anisomorphism and disarray of cardiomyocytes ; electron microscopy showed large stacks of severely dysmorphic megamitochondria and focal Z-disc streaming. In case-2, endomyocardial biopsy revealed moderate myoctyte hypertrophy with mild interstitial fibrosis ; transmission electron microscopy showed misalignment of Z-bands and unequal Z-Z band distances. Genetic analysis identified two heterozygous missense mutations in TNNI3, with R204H in case-1 and R192H in case-3 respectively. A de rtovo heterozygous deletion in TNNT2 (p. AsnlOO_Glul01del ) was identified in case-2. Sequence analysis shows that all three mutations are located in a position highly conserved across many species. The three mutations were negative for their parents and controls. Conclusion The clinical conditions in all three index cases are deteriorated rapidly after diagnosed as primary RCM. Three heterozygous mutations including two in TNN13 and one in TNNT2 gene are identified in the three RCMs respectively, which are considered as causative mutations. These findings provide new insights into the molecular etiology responsible for pediatric RCM.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2013年第4期304-309,共6页 Chinese Journal of Cardiology
基金 南京市医学科技发展资金项目(宁卫科字[2011]32号第二层次02) 国家自然科学资金资助项目(81000076)
关键词 心肌病 限制性 突变 Cardiomyopathy, restrictive Mutation
  • 相关文献

参考文献24

  • 1Dipchand AI, Naftel DC, Feingold B, et al. Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study. 1 Heart Lung Transplant, 2009,28:1312-1321.
  • 2Weller RJ, Weintraub R, Addonizio W, et al. Outcome of idiopathic restrictive cardiomyopathy in children. Am 1 Cardiol, 2002,90 :501-506.
  • 3Mogensen 1, Kubo T, Duque M, et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. 1 Clin Inves, 2003, 111 :209-216.
  • 4Kaski IP, Syrris P, Burch M, et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Heart, 2008,94: 1478 -1484.
  • 5Ware SM, Quinn ME, Ballard ET, et al. Pediatric restrictive cardiomyopathy associated with a mutation in beta-myosin heavy chain. Clin Genet, 2008, 73:165-170.
  • 6Menon SC, Michels VV, Pellikka P A, et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet, 2008, 74:445454.
  • 7Peddy SB, V ricella LA, Crosson IE, et al. Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene. Pediatrics, 2006,117: 1830-1833.
  • 8Caleshu C, Sakhuja R, Nussbaum RL, et al. Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy. Am 1 Med Genet A, 2011 , 155A:2229-2235.
  • 9Maron nr, Towhin lA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation, 2006, 113 : 1807-1816.
  • 10Fenton Ml, Chubb H, McMabon AM, et al. Heart and heart-lung transplantation for idiopathic restrictive cardiomyopathy in children. Heart, 2006,92 :85-89.

二级参考文献38

  • 1刘文玲,谢文丽,胡大一,朱天刚,李运田,孙艺红,李翠兰,李蕾,李田昌,边红,仝其广,杨松娜,范瑞云,崔炜.十个汉族家族性肥厚型心肌病MYH7、MYBPC3和TNNT2基因筛查结果及相应的临床特征[J].中华心血管病杂志,2006,34(3):202-207. 被引量:25
  • 2王曙霞,邹玉宝,傅春燕,宋雷,王虎,王继征,宋晓东,陈敬洲,惠汝太.心脏型肌钙蛋白T基因14035c>t突变导致家族性肥厚型心肌病的临床表型分析[J].中华医学杂志,2007,87(6):371-374. 被引量:2
  • 3Maron B J, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J, 2003, 24 : 1965-1991.
  • 4Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell, 2001, 104:557-567.
  • 5Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysio1,2008,19 : 104-110.
  • 6Gomes AV, Harada K, Potter JD. A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca (2 + )-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin. J Mol Cell Cardiol, 2005, 39:754-765.
  • 7Kruger M, Zittrich S, Redwood C, et al. Effects of the mutation R145G in human cardiac troponin I on the kinetics of the contraction-relaxation cycle in isolated cardiac myofibrils. J Physiol, 2005, 564 Pt 2:347-357.
  • 8Tsoutsman T, Chung J, Doolan A, et al. Molecular insights from a novel cardiac troponin I mouse model of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol, 2006, 41:623-632.
  • 9Brito D, Madeira H. Malignant mutations in hypertrophic cardiomyopathy : fact or fancy? Rev Port Cardiol, 2005,24 : 1137- 1146.
  • 10Anversa P,Sussman MA,Bolli R.Molecular genetic advances in cardiovascular medicine:focus on the myocyte.Circulation,2004,109:2832-2838.

共引文献4

同被引文献66

  • 1郭然,王珂,郑晓群,张晓红.以体循环淤血为主要表现的淀粉样变性心肌病临床特点分析[J].中国循环杂志,2005,20(4):283-284. 被引量:2
  • 2孙贵斌,金京浩.缩窄性心包炎与限制型心肌病的临床鉴别:附2例误诊报告[J].工企医刊,1990(1):19-21. 被引量:1
  • 3Maron B J, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies an American heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation, 2006, 113:1807-1816.
  • 4Elliott P, Andersson B, Arbustini E, et al. Classification of the eardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J, 2008, 29: 270-276.
  • 5Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med, 2003, 348: 1639-1646.
  • 6Sliwa K, Mayosi BM. Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart, 2013, 99: 1317-1322.
  • 7Russo LM, Webber SA. Idiopathic restrictive cardiomyopathy in children. Heart, 2005, 91:1199-1202.
  • 8Rivenes SM, Kearney DL, Smith EO, et al. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation, 2000, 102: 876-882.
  • 9Merlo M, Abate E, Pinamonti B, et al. Restrictive cardiomyopathy: clinical assessment and imaging in diagnosis and patient management. Clinical echocardiography and other imaging techniques in cardiomyopathies. Germany: Springer International Publishing, 2014. 185-206.
  • 10Mookadam F, Jiamsripong P, Raslan SF, et al. Constrictive pericarditis and restrictive cardiomyopathy in the modern era. Future cardiology, 2011, 7: 471-483.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部